Article
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
Science (New York, N.Y.) - 14 Jan 2022
Reynolds Catherine J, Gibbons Joseph M, Pade Corinna, Lin Kai-Min, Sandoval Diana Muñoz, Pieper Franziska, Butler David K, Liu Siyi, Otter Ashley D, Joy George, Menacho Katia, Fontana Marianna, Smit Angelique, Kele Beatrix, Cutino-Moguel Teresa, Maini Mala K, Noursadeghi Mahdad, Brooks Tim, Semper Amanda, Manisty Charlotte, Treibel Thomas A, Moon James C, McKnight Áine, Altmann Daniel M, Boyton Rosemary J
Abstract excerpt
The impact of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting strain on downstream immunity to heterologous variants of concern (VOCs) is unknown. Studying a longitudinal healthcare worker cohort, we found that after three antigen exposures (infection plus two vaccine doses), S1 antibody, memory B cells, and heterologous neutralization of B.1.351, P.1, and B.1.617.2 plateaued,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
